These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 32844349)

  • 1. Radiomics in Hepatocellular Carcinoma.
    Sagir Kahraman A
    J Gastrointest Cancer; 2020 Dec; 51(4):1165-1168. PubMed ID: 32844349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics, Radiogenomics, and Next-Generation Molecular Imaging to Augment Diagnosis of Hepatocellular Carcinoma.
    Bell M; Turkbey EB; Escorcia FE
    Cancer J; 2020; 26(2):108-115. PubMed ID: 32205534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of
    Lee SM; Kim HS; Lee S; Lee JW
    World J Gastroenterol; 2019 Mar; 25(11):1289-1306. PubMed ID: 30918424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care?
    Hesketh RL; Zhu AX; Oklu R
    Am J Clin Oncol; 2015 Aug; 38(4):431-6. PubMed ID: 25238287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCC and Tumor Biomarkers: Does One Size Fits All?
    Ozgor D; Otan E
    J Gastrointest Cancer; 2020 Dec; 51(4):1122-1126. PubMed ID: 32827068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint.
    Karadag Soylu N
    J Gastrointest Cancer; 2020 Dec; 51(4):1176-1186. PubMed ID: 32844348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
    Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
    Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress of radiomics with artificial intelligence in precise diagnosis and treatment of hepatocellular carcinoma].
    Li YH; Jia WD
    Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):905-909. PubMed ID: 33256273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
    Cho E; Jun CH; Kim BS; Son DJ; Choi WS; Choi SK
    Turk J Gastroenterol; 2015 Jul; 26(4):344-50. PubMed ID: 26039005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinoma.
    Wei J; Jiang H; Zhou Y; Tian J; Furtado FS; Catalano OA
    Dig Liver Dis; 2023 Jul; 55(7):833-847. PubMed ID: 36641292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics and radiogenomics of primary liver cancers.
    Jeong WK; Jamshidi N; Felker ER; Raman SS; Lu DS
    Clin Mol Hepatol; 2019 Mar; 25(1):21-29. PubMed ID: 30441889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of [
    Ye YF; Wang W; Wang T; Yu J; Geng L; Yu SF; Yan S; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):257-263. PubMed ID: 28603093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
    Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
    Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of hepatocellular carcinoma.
    Mendizabal M; Reddy KR
    Med Clin North Am; 2009 Jul; 93(4):885-900, viii. PubMed ID: 19577120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinventing radiation therapy with machine learning and imaging bio-markers (radiomics): State-of-the-art, challenges and perspectives.
    Dercle L; Henry T; Carré A; Paragios N; Deutsch E; Robert C
    Methods; 2021 Apr; 188():44-60. PubMed ID: 32697964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
    Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
    J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma.
    Hectors SJ; Lewis S; Besa C; King MJ; Said D; Putra J; Ward S; Higashi T; Thung S; Yao S; Laface I; Schwartz M; Gnjatic S; Merad M; Hoshida Y; Taouli B
    Eur Radiol; 2020 Jul; 30(7):3759-3769. PubMed ID: 32086577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.